Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

PURPOSE: Clinical features characteristic of small-cell prostate carcinoma (SCPC), (““anaplastic””) often emerge during the progression of prostate cancer. We sought to determine the efficacy of platinum-based chemotherapy in patients meeting at least one of seven prospectively defined “anaplastic”...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aparicio, Ana M., Harzstark, Andrea L., Corn, Paul G., Wen, Sijin, Araujo, John C., Tu, Shi-Ming, Pagliaro, Lance C., Kim, Jeri, Millikan, Randall E., Ryan, Charles J., Tannir, Nizar M., Zurita, Amado J., Mathew, Paul, Arap, Wadih, Troncoso, Patricia, Thall, Peter F., Logothetis, Christopher J.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699964/
https://ncbi.nlm.nih.gov/pubmed/23649003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3791
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars